Cannabinoids and pain: sites and mechanisms of action

K Starowicz, DP Finn - Advances in Pharmacology, 2017 - Elsevier
The endocannabinoid system, consisting of the cannabinoid 1 receptor (CB 1 R) and
cannabinoid 2 receptor (CB 2 R), endogenous cannabinoid ligands (endocannabinoids) …

Pharmacological characteristics of metamizole

A Jasiecka, T Maslanka… - Polish journal of veterinary …, 2014 - agro.icm.edu.pl
Metamizole (dipyrone) is a popular analgetic, non-opioid drug, commonly used in human
and veterinary medicine. In some cases, this agent is still incorrectly classified as a non …

Pain modulation: from conditioned pain modulation to placebo and nocebo effects in experimental and clinical pain

J Damien, L Colloca, CÉ Bellei-Rodriguez… - International review of …, 2018 - Elsevier
Accumulating evidence reveal important applications of endogenous pain modulation
assessment in healthy controls and in patients in clinical settings, as dysregulations in the …

Pain and the context

E Carlino, E Frisaldi, F Benedetti - Nature Reviews Rheumatology, 2014 - nature.com
Pain is a sensory and emotional experience that is substantially modulated by
psychological, social and contextual factors. Research now indicates that the influence of …

Different contexts, different pains, different experiences

E Carlino, F Benedetti - Neuroscience, 2016 - Elsevier
Pain is an ambiguous perception: the same pain stimulation can be perceived differently in
different contexts, producing different experiences, ranging from mild to unbearable pain. It …

[HTML][HTML] Cannabis and pain: a scoping review

C Pantoja-Ruiz, P Restrepo-Jimenez… - Brazilian Journal of …, 2022 - SciELO Brasil
For centuries, cannabis has been used with many different purposes, including medicinal
use, usually bypassing any formal approval process. However, during the last decade …

Metamizole/dipyrone for the relief of cancer pain: A systematic review and evidence-based recommendations for clinical practice

J Gaertner, UM Stamer, C Remi, R Voltz… - Palliative …, 2017 - journals.sagepub.com
Background: Dipyrone (metamizole) is one of the most widely used non-opioid analgesics
for the treatment of cancer pain. Aim: Because evidence-based recommendations are not …

Dipyrone is the preferred nonopioid analgesic for the treatment of acute and chronic pain. A survey of clinical practice in German‐speaking countries

L Reist, J Erlenwein, W Meissner… - … journal of pain, 2018 - Wiley Online Library
Purpose Nonopioid analgesics are frequently used for the treatment of acute and chronic
pain. Dipyrone is an alternative to NSAID s and paracetamol, however, data on the …

The endocannabinoid system as a potential therapeutic target for pain modulation

A Ulugöl - Balkan medical journal, 2014 - dergipark.org.tr
Although cannabis has been used for pain management for millennia, very few approved
cannabinoids are indicated for the treatment of pain and other medical symptoms …

“Redundancy” of endocannabinoid inactivation: new challenges and opportunities for pain control

F Piscitelli, V Di Marzo - ACS chemical neuroscience, 2012 - ACS Publications
Redundancy of metabolic pathways and molecular targets is a typical feature of all lipid
mediators, and endocannabinoids, which were originally defined as endogenous agonists …